KTT19: Psychotropic medicines in people with learning disabilities whose behaviour challenges Key Therapeutic Topic January 2017 Unclassified
KTT21: Medicines optimisation in long-term pain Key Therapeutic Topic January 2017 Unclassified
KTT18: Multimorbidity and polypharmacy Key Therapeutic Topic January 2017 Unclassified
KTT20: Safer insulin prescribing Key Therapeutic Topic January 2017 Unclassified
Do not routinely offer self-monitoring of blood glucose levels for adults with type 2 diabetes unless: the person is on insulin or there is evidence of hypoglycaemic episodes or the person is on oral medication that may increase their risk of hypoglycaemia while driving or operating machinery or the person is pregnant, or is planning to become pregnant. For more information, see the NICE guideline on diabetes in pregnancy. [new 2015] Do not do recommendation December 2016
Do not offer aspirin for the primary prevention of cardiovascular disease to adults with type 1 diabetes. Do not do recommendation December 2016
Men with idiopathic semen abnormalities should not be offered antioestrogens, gonadotrophins, androgens, bromocriptine or kinin-enhancing drugs because they have not been shown to be effective. Do not do recommendation December 2016
Testing for Y chromosome microdeletions should not be regarded as a routine investigation before ICSI. However, it is likely that a significant proportion of male infertility results from abnormalities of genes on the Y chromosome involved in the regulation of spermatogenesis, and couples should be informed of this. Do not do recommendation December 2016
Replacement of embryos into a uterine cavity with an endometrium of less than 5 mm thickness is unlikely to result in a pregnancy and is therefore not recommended. Do not do recommendation December 2016
The use of basal body temperature charts to confirm ovulation does not reliably predict ovulation and is not recommended. Do not do recommendation December 2016